Our research group has recently shown that WT1 is a marker that can be expressed at the cytoplasmic level in childhood fibrosarcoma, juvenile-type fibromatoses, and rhabdomyosarcoma [33,34,35,36,37,38,39]. Here, WT1 is linked to rhabdomyosarcoma.